Helen Katrina Tayton Martin Adaptimmune Therapeutics PLC (ADAP) insider trading activity

ADAP Quotes by TradingView

Helen Katrina Tayton Martin is Chief Business & Strgy Officer of Adaptimmune Therapeutics PLC. Currently has a direct ownership of 1.8 Million shares of ADAP, which is worth approximately $2.2 Million. The most recent transaction as insider was on Mar 03, 2021, when has been sold 1,785,000 shares (Ordinary Shares with a nominal value of GBP0.001 per share) at a price of $0.16 per share, resulting in proceeds of $285,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.8M
0% 3M change
0% 12M change
Total Value Held $2.2 Million

HELEN KATRINA TAYTON-MARTIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2021
BUY
Exercise of conversion of derivative security
$285,600 $0.16 p/Share
1,785,000 Added 49.79%
1,800,000 Ordinary Shares with a...
HKT

Helen Katrina Tayton Martin

Chief Business & Strgy Officer
Abingdon, X0

Track Institutional and Insider Activities on ADAP

Follow Adaptimmune Therapeutics PLC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADAP shares.

Notify only if

Insider Trading

Get notified when an Adaptimmune Therapeutics PLC insider buys or sells ADAP shares.

Notify only if

News

Receive news related to Adaptimmune Therapeutics PLC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADAP